Stocks in play: Sirona Biochem Corp.
Announced that the final toxicology test, a Human Repeated Insult Patch Test, has successfully been completed. Sirona is now in preparation for the increased dose (0.4%) clinical study for its skin lightening compound TFC-1067. Sirona Biochem Corp. shares V.SBM are trading unchanged at $0.47.